EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The role of HMGB1 in vascular endothelial cells

Duzhe Jiang, Ye Zhou, Junying Duan, Wei Zhong, Junjie Liu, Rui Chen, Wei Yuan

Apoptosis · 2026

DOI: 10.1007/s10495-026-02406-y ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Apoptosis, 2026. Verfasst von Duzhe Jiang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, Jiangsu, China. Hauptthemen laut MEDLINE: HMGB1 Protein, Endothelial Cells. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 175 Literaturangaben. Gefördert von: Social Development Foundation of Zhenjiang, Zhenjiang Program for Medical Technology Innovation, Zhenjiang Basic Research Project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

High-mobility group box 1 (HMGB1) is a damage-associated molecular pattern molecule that plays a key role in inflammatory responses and vascular injury. This article elucidates the underlying mechanisms by which HMGB1 regulates the pro-inflammatory phenotypic transformation of vascular endothelial cells (ECs), disrupts vascular barrier homeostasis, bidirectionally regulates angiogenesis, and induces various forms of programmed cell death, such as pyroptosis and ferroptosis, through core receptors, including the receptor for advanced glycation end-products and Toll-like receptors 2 and 4. We also elaborate on how HMGB1 participates in the occurrence and progression of diseases, such as sepsis, pulmonary hypertension, atherosclerosis, ischemia-reperfusion injury, tumors and lung injury, by regulating the biological behaviors of ECs. Although targeting HMGB1 in ECs has significant therapeutic potential, there remains a gap in clinical translation: how to develop novel intervention drugs that can accurately identify the pathogenic conformation of HMGB1 and possess high endothelial targeting capability. This review also summarizes the therapeutic strategies targeting endothelial HMGB1 reported in the literature.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HMGB1 ProteinEndothelial CellsHumansAnimalsReceptor for Advanced Glycation End ProductsApoptosisInflammationSignal TransductionToll-Like Receptor 4

Stichwörter der Autor:innen

Cell deathEndothelial cellsHMGB1InflammationTargeted therapy

Substanzen

HMGB1 ProteinHMGB1 protein, humanReceptor for Advanced Glycation End ProductsToll-Like Receptor 4

Autor:innen und Institutionen

  • Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, Jiangsu, China.
  • Department of Emergency, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, Jiangsu, China.
  • Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, Jiangsu, China. 1000011995@ujs.edu.cn.
  • Department of Cardiology, Affiliated Hospital of Jiangsu University, Zhenjiang, 212000, Jiangsu, China. yuanwei1@medmail.com.cn.

Förderung

  • Social Development Foundation of Zhenjiang
  • Zhenjiang Program for Medical Technology Innovation
  • Zhenjiang Basic Research Project

Zitieren

APA

Jiang, D., Zhou, Y., Duan, J., Zhong, W., Liu, J., Chen, R., & Yuan, W. (2026). The role of HMGB1 in vascular endothelial cells. Apoptosis. https://doi.org/10.1007/s10495-026-02406-y

Vancouver

Jiang D, Zhou Y, Duan J, Zhong W, Liu J, Chen R, et al. The role of HMGB1 in vascular endothelial cells. Apoptosis. 2026. doi:10.1007/s10495-026-02406-y

BibTeX
@article{Jiang2026,
  author = {Jiang, Duzhe and Zhou, Ye and Duan, Junying and Zhong, Wei and Liu, Junjie and Chen, Rui and Yuan, Wei},
  title = {The role of HMGB1 in vascular endothelial cells},
  journal = {Apoptosis},
  year = {2026},
  doi = {10.1007/s10495-026-02406-y}
}
Kostenlos starten →